123 related articles for article (PubMed ID: 21596673)
21. Effectiveness of meningococcal serogroup C vaccine programmes.
Borrow R; Abad R; Trotter C; van der Klis FR; Vazquez JA
Vaccine; 2013 Sep; 31(41):4477-86. PubMed ID: 23933336
[TBL] [Abstract][Full Text] [Related]
22. Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein.
Xu L; Li Z; Su Z; Yang Y; Ma G; Yu R; Zhang S
Vaccine; 2019 Feb; 37(7):956-964. PubMed ID: 30655174
[TBL] [Abstract][Full Text] [Related]
23. Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: evidence for increased levels of serum bactericidal antibodies.
Brodszki N; Skattum L; Bai X; Findlow H; Borrow R; Jönsson G
Vaccine; 2015 Apr; 33(15):1839-45. PubMed ID: 25707694
[TBL] [Abstract][Full Text] [Related]
24. Memory immune response generated in Cercopithecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine.
Carmenate T; Guirola M; Alvarez A; Canaán L; González S; Caballero E; Menéndez T; Guillén G
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):133-40. PubMed ID: 15681142
[TBL] [Abstract][Full Text] [Related]
25. Meningococcal A vaccination response is enhanced by acute stress in men.
Edwards KM; Burns VE; Adkins AE; Carroll D; Drayson M; Ring C
Psychosom Med; 2008 Feb; 70(2):147-51. PubMed ID: 18256346
[TBL] [Abstract][Full Text] [Related]
26. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.
MacLennan J; Obaro S; Deeks J; Lake D; Elie C; Carlone G; Moxon ER; Greenwood B
J Infect Dis; 2001 Jan; 183(1):97-104. PubMed ID: 11087205
[TBL] [Abstract][Full Text] [Related]
27. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
[TBL] [Abstract][Full Text] [Related]
28. Meningococcal serogroup C polysaccharide specific memory B cells, directly enumerated by labeled polysaccharide, are not affected by age at vaccination.
Henneken M; Burdin N; Thoroddsen E; Sigurdardottir ST; Trannoy E; Jonsdottir I
Vaccine; 2010 Feb; 28(9):2097-103. PubMed ID: 20056181
[TBL] [Abstract][Full Text] [Related]
29. Natural and vaccine-induced immunity to Neisseria meningitidis serogroup C in asplenic patients with β-thalassemia.
Spoulou V; Tzanakaki G; Lekka S; Chouliaras G; Ladis V; Theodoridou M
Vaccine; 2011 Jun; 29(27):4435-8. PubMed ID: 21497638
[TBL] [Abstract][Full Text] [Related]
30. Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency.
Rezaei N; Siadat SD; Aghamohammadi A; Moin M; Pourpak Z; Norouzian D; Mobarakeh JI; Aghasadeghi MR; Nejati M; Read RC
Clin Vaccine Immunol; 2010 Apr; 17(4):524-8. PubMed ID: 20106999
[TBL] [Abstract][Full Text] [Related]
31. Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.
Trotter CL; Borrow R; Findlow J; Holland A; Frankland S; Andrews NJ; Miller E
Clin Vaccine Immunol; 2008 Nov; 15(11):1694-8. PubMed ID: 18827191
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults.
de Voer RM; van der Klis FR; Engels CW; Schepp RM; van de Kassteele J; Sanders EA; Rijkers GT; Berbers GA
Vaccine; 2009 Nov; 27(50):6974-82. PubMed ID: 19800445
[TBL] [Abstract][Full Text] [Related]
33. Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controls.
Borrow R; Southern J; Andrews N; Peake N; Rahim R; Acuna M; Martin S; Miller E; Kaczmarski E
Vaccine; 2001 Apr; 19(23-24):3043-50. PubMed ID: 11311998
[TBL] [Abstract][Full Text] [Related]
34. Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia.
Jokhdar H; Borrow R; Sultan A; Adi M; Riley C; Fuller E; Baxter D
Clin Diagn Lab Immunol; 2004 Jan; 11(1):83-8. PubMed ID: 14715549
[TBL] [Abstract][Full Text] [Related]
35. Comparison of three ELISA protocols to measure antibody responses elicited against serogroup C meningococcal polysaccharide in mouse, monkey and human sera.
Guirola M; Carmenate T; Menéndez T; Alvarez A; González S; Guillén G
J Microbiol Methods; 2006 Apr; 65(1):135-43. PubMed ID: 16122825
[TBL] [Abstract][Full Text] [Related]
36. Opsonophagocytosis versus complement bactericidal killing as effectors following Neisseria meningitidis group C vaccination.
Gomez-Lus ML; Giménez MJ; Vázquez JA; Aguilar L; Anta L; Berrón S; Laguna B; Prieto J
Infection; 2003 Jan; 31(1):51-4. PubMed ID: 12590334
[TBL] [Abstract][Full Text] [Related]
37. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
[TBL] [Abstract][Full Text] [Related]
38. Avidity of serogroup A meningococcal IgG antibodies after immunization with different doses of a tetravalent A/C/Y/W135 polysaccharide vaccine.
Bårnes GK; Naess LM; Rosenqvist E; Guerin PJ; Caugant DA;
Scand J Immunol; 2011 Jul; 74(1):87-94. PubMed ID: 21332570
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003.
Soriano-Gabarró M; Toé L; Tiendrebeogo SR; Nelson CB; Dabal M; Djingarey MH; Plikaytis B; Rosenstein N;
Vaccine; 2007 Sep; 25 Suppl 1():A92-6. PubMed ID: 17517451
[TBL] [Abstract][Full Text] [Related]
40. Response of steroid-treated former preterm infants to a single dose of meningococcal C conjugate vaccine.
Clarke P; Robinson MJ; Ahmad I; Bedford-Russell AR; Connell JE; Powell PJ; Heath PT
Vaccine; 2006 Apr; 24(16):3273-8. PubMed ID: 16472548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
